Pathways to psychiatric disorder
Nature Neuroscience
January 20, 2015
Common psychiatric disorders such as schizophrenia, bipolar disorder and major depression share genetic risk factors related to immune function and changes in DNA expression, reports a study published online this week in Nature Neuroscience.
Hundreds of genetic differences across the human genome slightly increase the risk for psychiatric conditions such as schizophrenia. It is not clear, however, how these genetic changes affect different biological processes that then go on to alter brain function.
Gerome Breen, Peter Holmans and colleagues analyzed genetic data from over sixty thousand participants, including individuals with schizophrenia, bipolar disorder, major depression, autism spectrum disorders and attention deficit hyperactivity disorder, as well as healthy individuals. When the authors grouped the genetic data for all disorders together, they found that genes relating to histone methylation (molecular changes that alter DNA expression) and immune function are risk factors associated with the development of these disorders. This begins to identify shared biology across disorders that may help in developing targeted treatments irrespective of exact diagnosis.
doi: 10.1038/nn.3922
Research highlights
-
Nov 26
Evolution: Ancient bird sticks its big beak into the evolutionary recordNature
-
Nov 25
Zoology: Mineral armour discovered in insectsNature Communications
-
Nov 24
Neuroscience: Social isolation evokes craving responses in the human brainNature Neuroscience
-
Nov 20
Archaeology: Transition from tribal to feudal living in 14th century impacted local ecosystemsScientific Reports
-
Nov 18
Ecology: Migration associated with faster pace of lifeNature Communications
-
Nov 17
Gene therapy: Concerns for the long-term safety of AAV gene therapyNature Biotechnology
